MicroRNAs in body fluids—the mix of hormones and biomarkers (original) (raw)

• Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854 (1993).
  Article CAS PubMed Google Scholar
• Wightman, B., Ha, I. & Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855–862 (1993).
  CAS PubMed Google Scholar
• Reinhart, B. J. et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901–906 (2000).
  CAS PubMed Google Scholar
• Pasquinelli, A. E. et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86–89 (2000).
  CAS PubMed Google Scholar
• Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811 (1998).
  CAS PubMed Google Scholar
• Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20 (2005).
  CAS PubMed Google Scholar
• Ambros, V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113, 673–676 (2003).
  CAS PubMed Google Scholar
• Lee, Y. et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051–4060 (2004).
  CAS PubMed PubMed Central Google Scholar
• Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
  CAS PubMed Google Scholar
• Lee, Y., Jeon, K., Lee, J. T., Kim, S. & Kim, V. N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663–4670 (2002).
  CAS PubMed PubMed Central Google Scholar
• Zeng, Y., Yi, R. & Cullen, B. R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl Acad. Sci. USA 100, 9779–9784 (2003).
  CAS PubMed PubMed Central Google Scholar
• Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415–419 (2003).
  CAS PubMed Google Scholar
• Yi, R., Qin, Y., Macara, I. G. & Cullen, B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011–3016 (2003).
  CAS PubMed PubMed Central Google Scholar
• Lund, E., Guttinger, S., Calado, A., Dahlberg, J. E. & Kutay, U. Nuclear export of microRNA precursors. Science 303, 95–98 (2004).
  CAS PubMed Google Scholar
• Gregory, R. I., Chendrimada, T. P. & Shiekhattar, R. MicroRNA biogenesis: isolation and characterization of the microprocessor complex. Methods Mol. Biol. 342, 33–47 (2006).
  CAS PubMed Google Scholar
• Kloosterman, W. P., Wienholds, E., Ketting, R. F. & Plasterk, R. H. Substrate requirements for let 7 function in the developing zebrafish embryo. Nucleic Acids Res. 32, 6284–6291 (2004).
  CAS PubMed PubMed Central Google Scholar
• Lytle, J. R., Yario, T. A. & Steitz, J. A. Target mRNAs are repressed as efficiently by microRNA binding sites in the 5′ UTR as in the 3′ UTR. Proc. Natl Acad. Sci. USA 104, 9667–9672 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lee, I. et al. New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites. Genome Res. 19, 1175–1183 (2009).
  CAS PubMed PubMed Central Google Scholar
• Place, R. F., Li, L. C., Pookot, D., Noonan, E. J. & Dahiya, R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl Acad. Sci. USA 105, 1608–1613 (2008).
  CAS PubMed PubMed Central Google Scholar
• Merritt W. M. et al. Dicer, Drosha, and outcome in patients with ovarian cancer. N. Engl. J. Med. 359, 2641–2650 (2008).
  CAS PubMed PubMed Central Google Scholar
• Melo, S. A. et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18, 303–315 (2010).
  CAS PubMed Google Scholar
• Melo, S. A. et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat. Genet. 41, 365–370 (2009).
  CAS PubMed PubMed Central Google Scholar
• He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522–531 (2004).
  CAS PubMed Google Scholar
• Bohnsack, M. T., Czaplinski, K. & Gorlich, D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10, 185–191 (2004).
  CAS PubMed PubMed Central Google Scholar
• Vasudevan, S., Tong, Y. & Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931–1934 (2007).
  CAS PubMed Google Scholar
• Wu, S. et al. Multiple microRNAs modulate p21 Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Oncogene 29, 2302–2308 (2010).
  CAS PubMed Google Scholar
• Petersen, C. P., Bordeleau, M. E., Pelletier, J. & Sharp, P. A. Short RNAs repress translation after initiation in mammalian cells. Mol. Cell 21, 533–542 (2006).
  CAS PubMed Google Scholar
• Mathonnet, G. et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317, 1764–1767 (2007).
  CAS PubMed Google Scholar
• Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834–838 (2005).
  CAS PubMed Google Scholar
• Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857–66 (2006).
  CAS PubMed Google Scholar
• Calin, G. A. et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99, 15524–15529 (2002).
  CAS PubMed PubMed Central Google Scholar
• Michael, M. Z., O'Connor, S. M., van Holst Pellekaan, N. G., Young, G. P. & James, R. J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1, 882–891 (2003).
  CAS PubMed Google Scholar
• Iorio, M. V. et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065–7070 (2005).
  CAS PubMed Google Scholar
• Ciafre, S. A. et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 334, 1351–1358 (2005).
  CAS PubMed Google Scholar
• Murakami, Y. et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25, 2537–2545 (2006).
  CAS PubMed Google Scholar
• He, H. et al. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl Acad. Sci. USA 102, 19075–19080 (2005).
  CAS PubMed PubMed Central Google Scholar
• Yanaihara, N. et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189–198 (2006).
  CAS PubMed Google Scholar
• Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103, 2257–2261 (2006).
  CAS PubMed PubMed Central Google Scholar
• Rosenfeld, N. et al. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol. 26, 462–469 (2008).
  CAS PubMed Google Scholar
• Bloomston, M. et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297, 1901–1908 (2007).
  CAS PubMed Google Scholar
• Meng, F. et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647–658 (2007).
  CAS PubMed Google Scholar
• Asangani, I. A. et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128–2136 (2008).
  CAS PubMed Google Scholar
• Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682–688 (2007).
  CAS PubMed Google Scholar
• Olive, V., Jiang, I. & He, L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 42, 1348–1354 (2010).
  CAS PubMed PubMed Central Google Scholar
• Peter, M. E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8, 843–852 (2009).
  CAS PubMed Google Scholar
• Bommer, G. T. et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298–1307 (2007).
  CAS PubMed Google Scholar
• Visone, R. et al. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26, 7590–7595 (2007).
  CAS PubMed Google Scholar
• Nam, E. J. et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res. 14, 2690–2695 (2008).
  CAS PubMed Google Scholar
• Le, M. T. et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23, 862–876 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ozen, M., Creighton, C. J., Ozdemir, M. & Ittmann, M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27, 1788–1793 (2008).
  CAS PubMed Google Scholar
• Fabbri, M., Ivan, M., Cimmino, A., Negrini, M. & Calin, G. A. Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin. Biol. Ther. 7, 1009–1019 (2007).
  CAS PubMed Google Scholar
• Calin, G. A. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA 101, 2999–3004 (2004).
  CAS PubMed PubMed Central Google Scholar
• Ota, A. et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64, 3087–3095 (2004).
  CAS PubMed Google Scholar
• Garzon, R. et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111, 3183–3189 (2008).
  CAS PubMed PubMed Central Google Scholar
• Fazi, F. et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12, 457–466 (2007).
  CAS PubMed Google Scholar
• Saunders, M. A., Liang, H. & Li, W. H. Human polymorphism at microRNAs and microRNA target sites. Proc. Natl Acad. Sci. USA 104, 3300–3305 (2007).
  CAS PubMed PubMed Central Google Scholar
• Chin, L. J. et al. A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res. 68, 8535–8540 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yang, H. et al. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res. 68, 2530–2537 (2008).
  CAS PubMed Google Scholar
• Ye, Y. et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev. Res. (Phila.) 1, 460–469 (2008).
  CAS Google Scholar
• Hoffman, A. E. et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 69, 5970–5977 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kontorovich, T., Levy, A., Korostishevsky, M., Nir, U. & Friedman, E. Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int. J. Cancer 127, 589–597 (2010).
  CAS PubMed Google Scholar
• Jazdzewski, K. et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc. Natl Acad. Sci. USA 105, 7269–7274 (2008).
  CAS PubMed PubMed Central Google Scholar
• Takamizawa, J. et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753–3756 (2004).
  CAS PubMed Google Scholar
• Schetter, A. J. et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299, 425–436 (2008).
  CAS PubMed PubMed Central Google Scholar
• Chung, G. E. et al. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. Oncol. Rep. 23, 113–119 (2010).
  CAS PubMed Google Scholar
• Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147–152 (2008).
  CAS PubMed PubMed Central Google Scholar
• Coulouarn, C., Factor, V. M., Andersen, J. B., Durkin, M. E. & Thorgeirsson, S. S. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28, 3526–3536 (2009).
  CAS PubMed PubMed Central Google Scholar
• Lawrie, C. H. et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141, 672–675 (2008).
  PubMed Google Scholar
• Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513–10518 (2008).
  CAS PubMed PubMed Central Google Scholar
• Lodes, M. J. et al. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS ONE 4, e6229 (2009).
  PubMed PubMed Central Google Scholar
• Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997–1006 (2008).
  CAS PubMed Google Scholar
• Hu, Z. et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 28, 1721–1726 (2010).
  PubMed Google Scholar
• Resnick, K. E. et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 112, 55–59 (2009).
  CAS PubMed Google Scholar
• Ng, E. K. et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58, 1375–1381 (2009).
  CAS PubMed Google Scholar
• Huang, Z. et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 127, 118–126 (2010).
  CAS PubMed Google Scholar
• Tsujiura, M. et al. Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer 102, 1174–1179 (2010).
  CAS PubMed PubMed Central Google Scholar
• Heneghan, H. M. et al. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann. Surg. 251, 499–505 (2010).
  PubMed Google Scholar
• Wang, J. et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res. (Phila.) 2, 807–813 (2009).
  CAS Google Scholar
• Ho, A. S. et al. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl. Oncol. 3, 109–113 (2010).
  PubMed PubMed Central Google Scholar
• Yamamoto, Y. et al. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 14, 529–538 (2009).
  CAS PubMed Google Scholar
• Miyachi, M. et al. Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem. Biophys. Res. Commun. 400, 89–93 (2010).
  CAS PubMed Google Scholar
• Wong, T. S. et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res. 14, 2588–2592 (2008).
  CAS PubMed Google Scholar
• Boeri M. et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl Acad. Sci. USA 108, 3713–3718 (2011).
  CAS PubMed PubMed Central Google Scholar
• Tanaka, M. et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE 4, e5532 (2009).
  PubMed PubMed Central Google Scholar
• Moussay, E. et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 108, 6573–6578 (2011).
  CAS PubMed PubMed Central Google Scholar
• Park, N. J. et al. Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 15, 5473–5477 (2009).
  CAS PubMed PubMed Central Google Scholar
• Liu, C. J. et al. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis. 16, 360–364 (2010).
  PubMed Google Scholar
• Hanke, M. et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 28, 655–661 (2010).
  CAS PubMed Google Scholar
• Weber, J. A. et al. The microRNA spectrum in 12 body fluids. Clin. Chem. 56, 1733–1741 (2010).
  CAS PubMed PubMed Central Google Scholar
• Zhu, W., Qin, W., Atasoy, U. & Sauter, E. R. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes 2, 89 (2009).
  PubMed PubMed Central Google Scholar
• Patnaik, S. K., Mallick, R. & Yendamuri, S. Detection of microRNAs in dried serum blots. Anal. Biochem. 407, 147–149 (2010).
  CAS PubMed PubMed Central Google Scholar
• Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).
  CAS PubMed Google Scholar
• El-Hefnawy, T. et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem. 50, 564–573 (2004).
  CAS PubMed Google Scholar
• Smalheiser, N. R. Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol. Direct. 2, 35–49 (2007).
  PubMed PubMed Central Google Scholar
• Thery, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569–579 (2002).
  CAS PubMed Google Scholar
• Hunter, M. P. et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3, e3694 (2008).
  PubMed PubMed Central Google Scholar
• Michael, A. et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 16, 34–38 (2010).
  CAS PubMed Google Scholar
• Taylor, D. D., Homesley, H. D. & Doellgast, G. J. Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments. Cancer Res. 40, 4064–4069 (1980).
  CAS PubMed Google Scholar
• Taylor, D. D. & Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13–21 (2008).
  CAS PubMed Google Scholar
• Rabinowits, G. et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10, 42–46 (2009).
  CAS PubMed Google Scholar
• Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470–1476 (2008).
  CAS PubMed PubMed Central Google Scholar
• Ohshima, K. et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS ONE 5, e13247 (2010).
  PubMed PubMed Central Google Scholar
• Cortez, M. A. & Calin, G. A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 9, 703–711 (2009).
  CAS PubMed Google Scholar
• Kosaka, N. et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442–17452 (2010).
  CAS PubMed PubMed Central Google Scholar
• Pigati, L. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 5, e13515 (2010).
  PubMed PubMed Central Google Scholar
• Vickers K. C. et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423–433 (2011).
  CAS PubMed PubMed Central Google Scholar
• Wang, K. et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248–7259 (2010).
  CAS PubMed PubMed Central Google Scholar
• Arroyo J. D. et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl Acad. Sci. USA 108, 5003–5008 (2011).
  CAS PubMed PubMed Central Google Scholar
• Chim, S. S. et al. Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 54, 482–490 (2008).
  CAS PubMed Google Scholar
• Chen, C. et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179 (2005).
  PubMed PubMed Central Google Scholar
• Kroh, E. M. et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298–301 (2010).
  CAS PubMed PubMed Central Google Scholar
• Fu, H. J. et al. A novel method to monitor the expression of microRNAs. Mol. Biotechnol. 32, 197–204 (2006).
  CAS PubMed Google Scholar
• Rossi, S. et al. Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications. Mamm. Genome 19, 526–540 (2008).
  CAS PubMed Google Scholar
• Ferdin, J., Kunej, T. & Calin, G. A. Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling. Technol. Cancer Res. Treat. 9, 123–138 (2010).
  CAS PubMed Google Scholar
• Beutler, E., Gelbart, T. & Kuhl, W. Interference of heparin with the polymerase chain reaction. Biotechniques 9, 166 (1990).
  CAS PubMed Google Scholar
• Peltier, H. J. & Latham, G. J. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14, 844–852 (2008).
  CAS PubMed PubMed Central Google Scholar
• Hummel, R., Hussey, D. J. & Haier, J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur. J. Cancer 46, 298–311 (2010).
  CAS PubMed Google Scholar
• Weiss, G. J. et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol. 19, 1053–1059 (2008).
  CAS PubMed Google Scholar
• Nakajima, G. et al. Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 3, 317–324 (2006).
  CAS PubMed Google Scholar
• Salter, K. H. et al. An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS ONE 3, e1908 (2008).
  PubMed PubMed Central Google Scholar
• Zhang, H. L. et al. Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 71, 326–331 (2011).
  CAS PubMed Google Scholar
• Li, A. et al. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res. 70, 5226–5237 (2010).
  CAS PubMed PubMed Central Google Scholar
• Cheng, H. et al. Circulating plasma miR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS ONE 6, e17745 (2011).
  CAS PubMed PubMed Central Google Scholar
• Vasilescu, C. et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS ONE 4, e7405 (2009).
  PubMed PubMed Central Google Scholar
• Wang, J. F. et al. Serum miR-1467a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Commun. 394, 184–188 (2010).
  CAS PubMed Google Scholar
• Cech, T. R. The efficiency and versatility of catalytic RNA: implications for an RNA world. Gene 135, 33–36 (1993).
  CAS PubMed Google Scholar